A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting protection against heart attacks, strokes, and early death. Scientists at Anglia Ruskin مزید پڑھیں